Key points from article :
Johnson & Johnson MedTech gears up for late 2024 US clinical trials of its Ottava robotic surgical system.
Ottava, designed to fit seamlessly into any operating room, aims to challenge Intuitive Surgical's da Vinci and other robotic surgery contenders.
Initially a joint venture between J&J and Verily, Ottava was fully acquired by J&J in 2019.
Ottava's unique design integrates robotic arms directly into a standard-sized patient bed, minimising its footprint.
Equipped with J&J's Ethicon surgical instruments, Ottava boasts an "invisible design" and adaptable four-arm system.
Upon regulatory approval, Ottava will join J&J's robotic portfolio alongside Monarch and Velys, expanding the company's surgical robotics offerings.
